PREVESH RUSTAGI: Open Payments
NPI 1245237411 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,305 in 107 payments from 20 companies in 2025. Trend: 2023 $20,549 · 2024 $21,072 · 2025 $2,305
Food & beverage: $2,203Education: $101
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 11 | $207 |
| Teva Pharmaceuticals USA, Inc. | 8 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $201 |
| ABBVIE INC. | 9 | $194 |
| Corium, LLC | 8 | $192 |
| Alkermes, Inc. | 8 | $188 |
| Neurocrine BioSciences, Inc. | 6 | $158 |
| Lundbeck LLC | 8 | $146 |
| Otsuka America Pharmaceutical, Inc. | 6 | $145 |
| Noven Therapeutics, LLC | 6 | $111 |
Products named: REXULTI, Jornay PM, CAPLYTA, VRAYLAR, Azstarys, ARISTADA, INGREZZA, Xelstrym.
Industry payments across IN — which companies pay providers there.
